Trisomy 21
Also known as Down syndrome, one of the most commonly screened chromosomal conditions.
Advanced Prenatal Screening • Dubai
Advanced insight. Gentle reassurance.
NIPT Plus is an advanced, non-invasive prenatal screening option designed to provide families and healthcare professionals with clearer information from the early stages of pregnancy.
- Science-led screening
- Thoughtful clinical support
- Dubai-based care
- Confidential process
01 — NIPT Plus
More information, through a simple maternal blood sample.
NIPT analyses cell-free DNA found in the mother’s blood to screen for selected chromosomal conditions. It is a screening test, not a diagnostic test, and results should be reviewed with a qualified healthcare professional.
- Non-invasive blood collection
- Screening from the early stages of pregnancy
- Designed to assess selected chromosomal conditions
- Results reviewed with a healthcare professional
1
Maternal Blood Sample
2
Cell-free DNA
3
Laboratory Analysis
4
Risk Assessment
NIPT is a screening test and does not provide a definitive diagnosis. High-chance results may require genetic counselling and diagnostic testing.
Why NIPT Plus
Designed around clarity, care and science.
Four considerations that shape every NIPT Plus screening, from timing to the guidance behind your results.
Early Screening
Screening may be available from the 10th week of pregnancy, subject to clinical suitability.
Non-Invasive Process
The test is performed using a maternal blood sample without an invasive prenatal procedure.
Advanced Analysis
Cell-free DNA is analysed to assess the chance of selected chromosomal conditions.
Professional Guidance
Reports should be reviewed with an authorised doctor, clinic or genetic counsellor.
Screening may be available from the 10th week of pregnancy, subject to clinical suitability.
The test is performed using a maternal blood sample without an invasive prenatal procedure.
Cell-free DNA is analysed to assess the chance of selected chromosomal conditions.
Reports should be reviewed with an authorised doctor, clinic or genetic counsellor.
A considered process, from consultation to clarity.
-
01
Consultation
Your healthcare professional reviews your pregnancy information and test suitability.
-
02
Sample Collection
A maternal blood sample is collected through an authorised clinic or collection partner.
-
03
Laboratory Analysis
The sample is processed and analysed according to the selected screening panel.
-
04
Report & Guidance
The screening report is shared through the appropriate healthcare channel and reviewed professionally.
Screening areas may include
Trisomy 18
Also known as Edwards syndrome, associated with significant developmental effects.
Trisomy 13
Also known as Patau syndrome, a rarer chromosomal condition.
Sex chromosome aneuploidies
Variations in the number of X or Y chromosomes.
Selected additional conditions
Additional conditions may be included depending on the selected panel.
Available screening options depend on the selected panel, pregnancy characteristics and clinical eligibility. Final panel content must be confirmed by Gen Art Health.
02 — About Gen Art Health
Dubai-based expertise with a human approach.
Gen Art Health brings together modern laboratory capabilities, clinical collaboration and thoughtful patient communication. Based in Dubai, we aim to make advanced prenatal screening easier to understand and more accessible through a professional and confidential process.
Our approach is built around scientific responsibility, clear communication and respect for every family’s individual journey.
- Scientific Responsibility
- Confidentiality
- Clear Communication
- International Standards
From 10 weeks
One maternal blood sample
Professional result review
Questions, answered with care.
NIPT (Non-Invasive Prenatal Testing) analyses cell-free DNA in a maternal blood sample to screen for selected chromosomal conditions. It is a screening test, not a diagnostic test.
Screening may be available from the 10th week of pregnancy, subject to clinical suitability confirmed by your healthcare professional.
No. NIPT is a screening test that assesses chance, not certainty. High-chance results are typically followed by genetic counselling and diagnostic testing.
A standard maternal blood sample is collected through an authorised clinic or collection partner, without an invasive prenatal procedure.
Depending on the selected panel, screening may include selected trisomies and sex chromosome aneuploidies. Final panel content is confirmed by Gen Art Health.
Turnaround time depends on the selected panel, sample quality and laboratory workflow. Your healthcare professional will confirm expected timing.
Suitability for twin pregnancies depends on the specific test and clinical circumstances. Please discuss this with your healthcare professional.
Results are shared through the appropriate healthcare channel, typically your referring clinic or doctor, and should be reviewed professionally.
Yes. A healthcare professional reviews your pregnancy information and confirms suitability before testing.
Yes. Patient information is handled with confidentiality throughout the screening process.
Speak with our team.
Contact Gen Art Health to learn more about NIPT Plus, clinical eligibility and sample collection options in Dubai.
- Phone +971 XX XXX XXXX
- WhatsApp +971 XX XXX XXXX
- Email hello@genarthealth.ae
- Location Dubai, United Arab Emirates